Skip to main content

Basel Medical Group Ltd

corporate_fare Company Profile

Basel Medical Group Ltd

BMGL·NASDAQ·Industrial Applications And Services·CIK 0002004489

Basel Medical Group Ltd is a BVI business company incorporated in the BVI that serves as the holding company of the Group, conducting operations through operating subsidiaries based in Singapore. Its operations are based in Singapore, with specialist clinics at 6 Napier Road, Gleneagles Medical Centre, and general practices at locations across Singapore including Suntec City, Grantral Mall, Toa Payoh Hub, Margaret Drive, Tampines and Gateway East. The Group currently has 13 medical practitioners, comprising four specialists and 9 general practitioners. Services provided by its clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions, and the clinics are equipped with facilities needed to perform a variety of procedures on site and minor surgical services. Major surgeries are carried out at Gleneagles Hospital, Mount Elizabeth Hospital, Mount Elizabeth Novena Hospital, Parkway East Hospital, Mount Alvernia Hospital, Farrer Park Hospital and other day surgery centers in Singapore where its medical practitioners are accredited to practice. The clinics have been selected by several insurance providers as preferred medical care providers, and its medical doctors are MediSave accredited, so patients can submit their MediSave or Integrated Shield Plan claims through the clinics. MediSave is a national medical savings scheme in Singapore that helps individuals set aside part of their income to pay for personal or approved dependents' hospitalization, day surgery and certain outpatient expenses, as well as healthcare needs in old age. MediShield Life is a basic national health insurance scheme in Singapore providing lifelong coverage for Singapore citizens and permanent residents; certain aspects are paid for using MediSave funds. Integrated Shield Plans are optional health coverage provided by private insurers that complements MediShield Life with higher coverage benefits.

Basel Medical Group Ltd (NASDAQ:BMGL) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for BMGL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-30, rated 8/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for BMGL spans 20-F, 424B4, F-1/A, F-1.

Recent high-impact activity:

  • Basel Medical FY2026: Revenue Up 45% to S$16.4M, But Material Weakness and Going-Concern Dependency Disclosed
  • Basel Medical Finalizes $7.98M Unit Offering at $1.33 — Zero-Cash Warrants Could Add 6M Shares
  • Basel Medical Prices 6M-Unit Offering at $1.33 with Zero-Cash Warrants
  • Basel Medical Group Files to Sell Up to 6M Units with Warrants
  • Basel Medical Files F-1 for Up to 6M Units with Zero-Cash Warrants

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$12.81M
Net Income
-$1.11M
Diluted EPS
-$0.61
Op. Cash Flow
-$531.96K
Free Cash Flow
-$723.77K
Cash & Equivalents
$409.46K
Total Debt
$2.62M
Debt / Equity
0.75×
Net Margin
-8.7%
Source: 20-F · filed 2026-10-30 · accession 0001493152-26-049381

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 107,869 shares in BMGL as of the October 30, 2026 settlement, a 731.6% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 45.0% of BMGL volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)107,869 shares as of October 30, 2026
Change vs prior period▲ 731.6%
Days to cover1.00 at avg daily volume of 1,433,048
Daily short volume (FINRA facilities)45.0% of 471,390 shares on November 20, 2026
5-day average short volume43.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for BMGL, detected from its recent SEC filings · based on capital-structure filings through 2026-10-08.

1 recent capital raise1 shelf registrationreverse split

6M-Unit Offering Finalized at $1.33 · Zero-Cash Warrants Add 6M More Shares

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

BMGL files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with B →
$0.3585 -6.45% today
52-week range · as of 2026-10-30 $0.3585 – $19.92
Market cap
$5.2M
Volume
1.1M (0.3× avg)
3-mo avg 4.1M
Live data · 2026-11-22 12:07 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BMGL - Latest Insights

BMGL
Oct 30, 2026, 11:26 AM EDT
Filing Type: 20-F
Importance Score:
8
Price at Filing: $4.99
Real-time Price: $0.3585 info
Change: -$4.63 (-93%) info
Market Cap: $5.205M info
BMGL
Oct 08, 2026, 4:46 PM EDT
Filing Type: 424B4
Importance Score:
8
Price at Filing: $3.65
Real-time Price: $0.3585 info
Change: -$3.29 (-90%) info
Market Cap: $5.205M info
BMGL
Sep 23, 2026, 4:06 PM EDT
Filing Type: F-1/A
Importance Score:
8
Price at Filing: $4.09
Real-time Price: $0.3585 info
Change: -$3.73 (-91%) info
Market Cap: $5.205M info
BMGL
Sep 17, 2026, 4:12 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.31
Real-time Price: $0.3585 info
Change: -$3.95 (-92%) info
Market Cap: $5.205M info
BMGL
Sep 17, 2026, 4:06 PM EDT
Filing Type: F-1
Importance Score:
8
Price at Filing: $4.31
Real-time Price: $0.3585 info
Change: -$3.95 (-92%) info
Market Cap: $5.205M info
BMGL
Aug 10, 2026, 6:30 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.70
Real-time Price: $0.3585 info
Change: -$5.34 (-94%) info
Market Cap: $5.205M info
BMGL
Jun 26, 2026, 8:22 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.71
Real-time Price: $0.3585 info
Change: -$6.35 (-95%) info
Market Cap: $5.205M info
BMGL
Jun 10, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.621
Real-time Price: $0.3585 info
Change: Reverse Stock Split info
Market Cap: $5.205M info
BMGL
Jun 05, 2026, 6:30 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3748
Real-time Price: $0.3585 info
Change: Reverse Stock Split info
Market Cap: $5.205M info
BMGL
Mar 24, 2026, 6:30 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7122
Real-time Price: $0.3585 info
Change: Reverse Stock Split info
Market Cap: $5.205M info
BMGL
Mar 13, 2026, 7:30 AM EDT
Filing Type: 20-F/A
Importance Score:
9
Price at Filing: $0.5827
Real-time Price: $0.3585 info
Change: Reverse Stock Split info
Market Cap: $5.205M info
BMGL
Jan 23, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7999
Real-time Price: $0.3585 info
Change: Reverse Stock Split info
Market Cap: $5.205M info
BMGL
Jan 21, 2026, 8:20 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.8123
Real-time Price: $0.3585 info
Change: Reverse Stock Split info
Market Cap: $5.205M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets